Print Page | Close Window

Update on Strategies to Improve TNBC Treatment

Printed From: TNBC Foundation
Category: TNBC Forums
Forum Name: TNBC Talk
Forum Description: A place to chat
URL: http://forum.tnbcfoundation.org/forum_posts.asp?TID=13863
Printed Date: Jul 06 2022 at 6:30am
Software Version: Web Wiz Forums 12.01 - http://www.webwizforums.com


Topic: Update on Strategies to Improve TNBC Treatment
Posted By: 123Donna
Subject: Update on Strategies to Improve TNBC Treatment
Date Posted: May 02 2022 at 10:41am

Update on Strategies to Improve Treatment for Triple Negative Breast Cancer

Checkpoint Inhibitors, and Sacituzumab Govitecan (IMMU-132) are promising TNBC treatment advances.

When patients are newly diagnosed with TNBC, they should  undergo NGS-biomarker testing to check for PD-L1 status, BRCA and other biomarkers that can identify individuals who can benefit from treatment with newer precision cancer medicines and immunotherapy.

https://news.cancerconnect.com/triple-negative-breast-cancer/update-on-strategies-to-improve-treatment-for-triple-negative-breast-cancer" rel="nofollow - https://news.cancerconnect.com/triple-negative-breast-cancer/update-on-strategies-to-improve-treatment-for-triple-negative-breast-cancer


-------------
DX IDC TNBC 6/09 age 49, Stage 1,Grade 3, 1.5cm,0/5Nodes,KI-67 48%,BRCA-,6/09bi-mx, recon, T/C X4(9/09)
11/10 Recur IM node, Gem,Carb,Iniparib 12/10,MRI NED 2/11,IMRT Radsx40,CT NED11/13,MRI NED3/15




Print Page | Close Window

Forum Software by Web Wiz Forums® version 12.01 - http://www.webwizforums.com
Copyright ©2001-2018 Web Wiz Ltd. - https://www.webwiz.net